Results 181 to 190 of about 3,363,784 (294)

Radiotherapy for Metastatic Bladder Cancer in the Era of Modern Systemic Therapies. [PDF]

Cureus
Herver Vazquez ME, Mora Montoya MJ, Coria Dominguez LA, Granados Sanchez EF.   +3 more
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Mechanobiology of Matricellular Proteins in Bladder Cancer: A Narrative Review and Bioinformatics Analysis. [PDF]

Biomolecules
Turgaliyev A, Konovalov R, Borissenko A, Riethmacher D.   +3 more
europepmc   +1 more source

Monitoring pharmacodynamic and molecular drug targets in liquid biopsy: Exploratory study in liver cancer with modelling of EGFR Receptor engagement

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Liquid biopsy is minimally invasive (compared with tissue biopsy) and has previously been used to generate systems data regarding drug elimination via hepatic enzymes and transporters. This study extends quantitative assessment of systems parameters in liquid biopsy to pharmacodynamic (PD) and disease markers relevant to cancer development
Zubida M. Al‐Majdoub, Armin Sepp, Amin Rostami‐Hodjegan, Brahim Achour   +3 more
wiley   +1 more source

Challenging Cases in Urothelial Cancer

Bladder Cancer, 2016
Mark S. Soloway
doaj   +1 more source

Urinary microbiota in bladder cancer: insights into pathogenesis, diagnosis, and therapeutic potential. [PDF]

Front Cell Infect Microbiol
Sheng Z, Zhu J, Sun J, Zeng S, Ding J, Zhang Z.   +5 more
europepmc   +1 more source

Utilization of immune checkpoint inhibitors for the treatment of cancer in Scotland, 2018–2024: A national retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of the study is to describe the use of immune checkpoint inhibitors (ICIs) for the treatment of cancer in Scotland. Methods The retrospective observational cohort study included patients aged 18 years or older who commenced treatment with an ICI in Scotland between 1 January 2018 and 31 December 2024.
Tanja Mueller, Christine Crearie, Liya Lu, Jiafeng Pan, Fraser N. Sneden, David Martin, Amanj Kurdi, Catherine S. Thomson, Julie Clarke, Marion Bennie   +9 more
wiley   +1 more source

Challenging Cases in Urothelial Cancer

Bladder Cancer, 2017
Mark S. Soloway
doaj   +1 more source

Associations between a mixture of trace elements and bladder cancer occurrence: A study of possible reverse causation. [PDF]

Environ Epidemiol
Kamenetsky ME, Koutros S, Spaur M, Kim SD, Karagas MR, Johnson A, Baris D, Le XC, Silverman DT, Keil AP.   +9 more
europepmc   +1 more source

Regulatory harmonization: Evolution, globalization and future directions

British Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm, Elaine Y. L. Blair, Christine Y. Lu   +2 more
wiley   +1 more source